Document Detail

The impact of pharmacogenetics in the treatment of allergic disease and asthma.
MedLine Citation:
PMID:  22073496     Owner:  NLM     Status:  MEDLINE    
Personalized medicine includes the application of genomic information in predicting disease and therapeutic response to ultimately individualize patient care. Pharmacogenetics is key in achieving true personalized care. However, the clinical applicability of genetic testing to "everyday medicine" is yet to be realized. This paper will discuss areas in allergic/inflammatory disease that have been impacted by pharmacogenetic research and how this application may be brought from the "bench to the bedside."
Bridgette L Jones
Related Documents :
22248326 - Role of endoplasmic reticulum stress in metabolic disease and other disorders.
21746926 - Insect olfaction from model systems to disease control.
22202096 - Integrating structure and function of 'tandem-repeat' galectins.
21727816 - From symptoms to causes: progress in the treatment of neurological disease.
24729766 - Colonoscopic perforation in inflammatory bowel disease.
22813736 - A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse mode...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Missouri medicine     Volume:  108     ISSN:  0026-6620     ISO Abbreviation:  Mo Med     Publication Date:    2011 Sep-Oct
Date Detail:
Created Date:  2011-11-11     Completed Date:  2011-12-13     Revised Date:  2013-05-24    
Medline Journal Info:
Nlm Unique ID:  0400744     Medline TA:  Mo Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  361-5     Citation Subset:  IM    
Department of Pediatrics, Children's Mercy Hospital and Clinics, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Inhalation
Adrenal Cortex Hormones / therapeutic use
Anti-HIV Agents / immunology,  therapeutic use
Asthma / genetics*,  therapy*
Bronchodilator Agents / therapeutic use
Dideoxynucleosides / immunology,  therapeutic use
Genetic Association Studies
Hypersensitivity / therapy*
Polymorphism, Single Nucleotide
Trimethoprim-Sulfamethoxazole Combination / therapeutic use
Reg. No./Substance:
0/Adrenal Cortex Hormones; 0/Anti-HIV Agents; 0/Bronchodilator Agents; 0/Dideoxynucleosides; 8064-90-2/Trimethoprim-Sulfamethoxazole Combination; WR2TIP26VS/abacavir

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Approach to patients with eosinophilia.
Next Document:  Prevalence of methicillin resistant Staphylococcus aureus in nasal samples from preclinical second-y...